Trajectory of criterion symptoms of major depression under newly started antidepressant treatment: sleep disturbances and anergia linger on while suicidal ideas and psychomotor symptoms disappear early.Objective: In modern psychiatry, depression is diagnosed with the diagnostic criteria; however, the trajectory of each of the criterion symptoms is unknown. This study aims to examine this. Methods: We made repeated assessments of the nine diagnostic criterion symptoms with the Patient Health Questionnaire-9 (PHQ-9) among 2011 participants of a 25-week pragmatic randomised controlled trial of sertraline and/or mirtazapine for hitherto untreated major depressive episodes. The changes from baseline were estimated with the mixedeffects model with repeated measures. The time to disappearance of each symptom was modeled using the Kaplan-Meier survival analysis. Results: The total score on PHQ-9 was 18.5 (SD = 3.9, n = 2011) at baseline, which decreased to 15.3 (5.2, n = 2011) at week 1, to 11.5 (5.9, n = 1953) at week 3, to 7.8 (6.0, n = 1927) at week 9, and to 6.0 (5.9, n = 1910) at week 25. Suicidal ideas, psychomotor symptoms decreased rapidly, while anergia and sleep disturbance also decreased but only slowly. The survival analyses confirmed the primary analyses. Conclusions: Upon initiation of antidepressant treatment, patients with newly treated major depressive episodes can expect their suicidal ideas and psychomotor symptoms to disappear first but sleep disturbances and anergia to linger on.
Significant outcomes• When one starts antidepressant treatment for a new major depressive episode, one can expect suicidal ideations and psychomotor symptoms to ameliorate first.• Concentration difficulties, anhedonia, appetite disturbance, low self-esteem, or depressed mood improve next. • However, anergia and sleep disturbances tend to decrease only slowly and to linger on.
Limitations• The findings come from a 25-week pragmatic randomized controlled trial of first-and second-line antidepressants. The medications included sertraline and mirtazapine, sometimes in combination with benzodiazepines where necessary, up to week 9, after which the treatment was at the discretion of the treating psychiatrists.• The trajectory of depression symptoms may be different under other treatments.